SRAX（SRAX）株式概要SRAX, Inc.は、米国、カナダ、および国際的な上場企業と株主・投資家とのコミュニケーション強化に注力しています。 詳細SRAX ファンダメンタル分析スノーフレーク・スコア評価0/6将来の成長0/6過去の実績0/6財務の健全性0/6配当金0/6リスク分析最新の財務報告は1年以上前のものである US市場と比較して、過去 3 か月間の株価の変動が非常に大きい意味のある時価総額がありません ( $327K )すべてのリスクチェックを見るSRAX Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair ValueUS$Current PriceUS$0.000699.9% 割安 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture-34m32m2016201920222025202620282031Revenue US$18.6mEarnings US$2.2mAdvancedSet Fair ValueView all narrativesSRAX, Inc. 競合他社FOXO TechnologiesSymbol: OTCPK:FOXOMarket cap: US$426.2kBaijiayun GroupSymbol: OTCPK:RTCJ.FMarket cap: US$195.9kFemto TechnologiesSymbol: OTCPK:FMTO.FMarket cap: US$700.4kDatalexSymbol: OTCPK:DLEX.YMarket cap: US$940.8k価格と性能株価の高値、安値、推移の概要SRAX過去の株価現在の株価US$0.000652週高値US$0.2452週安値US$0.0001ベータ01ヶ月の変化-94.59%3ヶ月変化-70.00%1年変化100.00%3年間の変化-99.76%5年間の変化-99.90%IPOからの変化-99.90%最新ニュースお知らせ • May 09DNA Holdings LLC entered into a definitive merger agreement to acquire remaining 65% stake in SRAX, Inc. (OTCPK:SRAX).DNA Holdings LLC entered into a definitive merger agreement to acquire remaining 65% stake in SRAX, Inc. (OTCPK:SRAX) on May 8, 2024. DNA has been a long term investor in SRAX and currently owns approximately 35% of the company. Upon closing, the shareholders of DNA will become the majority owners of SRAX’s outstanding common stock. Upon the completion of the merger, the public company plans to change its name to DNA Holdings Venture Inc and to request to change its ticker symbol, creating a public company which will allow investors to gain exposure to the most cutting edge Web3 technology projects. Christopher Miglino will act as the CEO of the combined entity. The boards of directors of SRAX and DNA have unanimously approved the proposed Transaction. The Transaction is subject to, among other things, the approval of both SRAX and DNA stockholders and satisfaction or waiver of the conditions stated in the Agreement.お知らせ • Apr 04SRAX, Inc. announced that it has received $0.075 million in fundingOn April 2, 2024, SRAX, Inc. closed the transaction.お知らせ • Mar 07SRAX, Inc. announced that it has received $0.075 million in fundingSRAX, Inc. announced that it has entered into definitive securities purchase agreements with a certain accredited and institutional investor to issue an Original Issue Discount Convertible Debenture at a price of $75,000 in the principal amount of $90,000 for gross proceeds of $75,000 on March 5, 2024. The Debentures will mature on February 28, 2026 and bear no interest per annum. The Debentures are convertible at the option of the holder into shares of our Class A common stock at an initial conversion price of $0.25 per share, subject to adjustment. The debentures issued are exempt from registration under the Securities Act of 1933, as amended in reliance on the exemption provided by Rule 506(b) of Regulation D and Section 4(a)(2) of the Securities Act.お知らせ • Jul 18SRAX, Inc. Announces Resignation of Board MembersOn July 11 and July 13th, SRAX, Inc. announced that Marc Savas, Robert Jordan, Colleen DiClaudio and Brock Pierce resigned from the board of directors and their respective committee roles of SRAX. There were no disagreements between Marc Savas, Robert Jordan, Colleen DiClaudio and Brock Pierce and the Company. Their departure is not related to the operations, policies or practices of the Company, or any issues regarding accounting policies or practices. Brock Pierce will transition to the Advisory Board. Christopher Miglino shall remain as the Chairman of the Board and shall assume the Governance, Compensation and Audit Committee chairman roles.お知らせ • Jul 10Alan Urban Resigns as the Chief Financial Officer of SRAX, IncOn July 5, 2023 Alan Urban resigned as the Chief Financial Officer of SRAX and has transitioned from the Chief Financial Officer of the company to a consultant to help the company complete its SEC Filings. Mr. Urban is resigning to exclusively focus his efforts on the companies’ fillings, and there were no disagreements between Mr. Urban and the Company. His departure is not related to the operations, policies or practices of the Company, or any issues regarding accounting policies or practices.New Risk • Jun 08New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: US$9.90m This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (48% average weekly change). Market cap is less than US$10m (US$9.90m market cap). Minor Risk Shareholders have been diluted in the past year (11% increase in shares outstanding).最新情報をもっと見るRecent updatesお知らせ • May 09DNA Holdings LLC entered into a definitive merger agreement to acquire remaining 65% stake in SRAX, Inc. (OTCPK:SRAX).DNA Holdings LLC entered into a definitive merger agreement to acquire remaining 65% stake in SRAX, Inc. (OTCPK:SRAX) on May 8, 2024. DNA has been a long term investor in SRAX and currently owns approximately 35% of the company. Upon closing, the shareholders of DNA will become the majority owners of SRAX’s outstanding common stock. Upon the completion of the merger, the public company plans to change its name to DNA Holdings Venture Inc and to request to change its ticker symbol, creating a public company which will allow investors to gain exposure to the most cutting edge Web3 technology projects. Christopher Miglino will act as the CEO of the combined entity. The boards of directors of SRAX and DNA have unanimously approved the proposed Transaction. The Transaction is subject to, among other things, the approval of both SRAX and DNA stockholders and satisfaction or waiver of the conditions stated in the Agreement.お知らせ • Apr 04SRAX, Inc. announced that it has received $0.075 million in fundingOn April 2, 2024, SRAX, Inc. closed the transaction.お知らせ • Mar 07SRAX, Inc. announced that it has received $0.075 million in fundingSRAX, Inc. announced that it has entered into definitive securities purchase agreements with a certain accredited and institutional investor to issue an Original Issue Discount Convertible Debenture at a price of $75,000 in the principal amount of $90,000 for gross proceeds of $75,000 on March 5, 2024. The Debentures will mature on February 28, 2026 and bear no interest per annum. The Debentures are convertible at the option of the holder into shares of our Class A common stock at an initial conversion price of $0.25 per share, subject to adjustment. The debentures issued are exempt from registration under the Securities Act of 1933, as amended in reliance on the exemption provided by Rule 506(b) of Regulation D and Section 4(a)(2) of the Securities Act.お知らせ • Jul 18SRAX, Inc. Announces Resignation of Board MembersOn July 11 and July 13th, SRAX, Inc. announced that Marc Savas, Robert Jordan, Colleen DiClaudio and Brock Pierce resigned from the board of directors and their respective committee roles of SRAX. There were no disagreements between Marc Savas, Robert Jordan, Colleen DiClaudio and Brock Pierce and the Company. Their departure is not related to the operations, policies or practices of the Company, or any issues regarding accounting policies or practices. Brock Pierce will transition to the Advisory Board. Christopher Miglino shall remain as the Chairman of the Board and shall assume the Governance, Compensation and Audit Committee chairman roles.お知らせ • Jul 10Alan Urban Resigns as the Chief Financial Officer of SRAX, IncOn July 5, 2023 Alan Urban resigned as the Chief Financial Officer of SRAX and has transitioned from the Chief Financial Officer of the company to a consultant to help the company complete its SEC Filings. Mr. Urban is resigning to exclusively focus his efforts on the companies’ fillings, and there were no disagreements between Mr. Urban and the Company. His departure is not related to the operations, policies or practices of the Company, or any issues regarding accounting policies or practices.New Risk • Jun 08New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: US$9.90m This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (48% average weekly change). Market cap is less than US$10m (US$9.90m market cap). Minor Risk Shareholders have been diluted in the past year (11% increase in shares outstanding).Reported Earnings • Jan 03First quarter 2022 earnings released: EPS: US$0.14 (vs US$0.57 loss in 1Q 2021)First quarter 2022 results: EPS: US$0.14 (up from US$0.57 loss in 1Q 2021). Revenue: US$7.50m (up 38% from 1Q 2021). Net income: US$3.73m (up US$14.8m from 1Q 2021). Profit margin: 50% (up from net loss in 1Q 2021). Revenue is forecast to grow 33% p.a. on average during the next 2 years, compared to a 13% growth forecast for the Software industry in the US. Over the last 3 years on average, earnings per share has fallen by 3% per year but the company’s share price has fallen by 15% per year, which means it is performing significantly worse than earnings.Breakeven Date Change • Dec 31Forecast breakeven date pushed back to 2023The analyst covering SRAX previously expected the company to break even in 2022. New forecast suggests the company will make a profit of US$12.3m in 2023. Average annual earnings growth of 117% is required to achieve expected profit on schedule.お知らせ • Dec 02SRAX, Inc., Annual General Meeting, Dec 31, 2022SRAX, Inc., Annual General Meeting, Dec 31, 2022, at 11:00 Pacific Standard Time. Agenda: To consider and approve Election of six (6) members to the board of directors (“Board”) to serve for the following year or until their respective successors are appointed and qualified; Ratification of the appointment of Marcum LLP as independent registered public accounting firm for 2022; and to discuss other matters.Price Target Changed • Nov 16Price target increased to US$10.50Up from US$9.75, the current price target is an average from 2 analysts. New target price is 518% above last closing price of US$1.70. Stock is down 67% over the past year. The company is forecast to post earnings per share of US$0.32 next year compared to a net loss per share of US$0.41 last year.お知らせ • Oct 22SRAX, Inc. Launches the Sequire Investor Community PlatformSRAX, Inc. has launched its beta program for retail and institutional investors - Sequire Community. The Sequire Community is an ever-growing community of like-minded individuals, education, and resources. Complementing Sequire’s suite of products connecting public companies with their shareholders, this new platform gives investors and companies the ability to interact in a different way - through virtual Q&A events that can be held alone or in addition to earnings calls. Companies will have the ability to: Create a company profile showcasing their bio, ticker, and stock price; Launch Q&A events; Answer verified investor’s questions; See the amount of stock owned by investors asking questions; Hear what is important to shareholders. Investors will have the opportunity to: Connect their brokerage account to become verified; Engage with companies directly by asking questions; Upvote other investor’s questions on a company’s profile; Give companies feedback; Explore company profiles and other investment opportunities. In the final version of the platform, companies and investors will be able to start threads, link websites into questions and answers, as well as upload images or graphs.お知らせ • Oct 21SRAX Announces Receipt of Nasdaq Listing DeterminationOn October 20, 2022, SRAX, Inc. announced that on October 14, 2022, the company received notice from the Nasdaq Listing Qualifications Staff (the ‘Staff’) indicating that the Staff had determined to delist the Company’s securities from Nasdaq unless the Company timely requests a hearing before the Nasdaq Hearings Panel (the ‘Panel’). The Staff’s determination was based upon the Company’s non-compliance with the filing requirement set forth in Nasdaq Listing Rule 5250(c)(1). On October 12, 2022, the Company filed its Annual Report on Form 10-K for the fiscal year ended December 31, 2021 with the Securities and Exchange Commission (the ‘SEC’); however, the Company has not yet filed the Quarterly Reports on Form 10-Q for the quarters ended March 31, 2022 and June 30, 2022 with the SEC. The Company plans to timely request a hearing before the Panel and, in accordance with Nasdaq Listing Rule 5815(a)(1)(B), a stay of any further suspension or delisting action by Nasdaq at least pending the issuance of a decision and the expiration of any extension that may be granted by the Panel following the hearing. At the hearing, the Company will present its plan to evidence compliance with the Filing Requirement and request an extension of time to do so. The Company is diligently working to file all necessary periodic reports with the SEC as soon as practicable; however, there can be no assurance that the Panel will determine to continue the company’s listing on Nasdaq or that the Company will be able to timely satisfy the terms of any extension that may be granted by the Panel as a result of the hearing.Seeking Alpha • Oct 20SRAX gets Nasdaq delisting notice, plans to appeal decisionSRAX (NASDAQ:SRAX) said Thursday it received a Nasdaq notice indicating that its shares will be delisted unless the firm timely requests a hearing before the Nasdaq Hearings Panel. Nasdaq's decision is based on SRAX's (SRAX) non-compliance with the filing requirement for continued listing. The company filed its annual report for the fiscal year ended Dec. 31, 2021 with the SEC on Oct. 12. But it has not yet filed the quarterly reports for the quarters ended Mar. 31 and Jun. 30. SRAX (SRAX) plans to timely request a hearing before the panel and stay any further suspension or delisting action by the exchange.Reported Earnings • Oct 13Full year 2021 earnings released: US$0.41 loss per share (vs US$0.69 loss in FY 2020)Full year 2021 results: US$0.41 loss per share (improved from US$0.69 loss in FY 2020). Revenue: US$26.7m (up 312% from FY 2020). Net loss: US$9.70m (loss narrowed 3.6% from FY 2020). Revenue is forecast to grow 36% p.a. on average during the next 2 years, compared to a 13% growth forecast for the Software industry in the US. Over the last 3 years on average, earnings per share has fallen by 39% per year but the company’s share price has only fallen by 6% per year, which means it has not declined as severely as earnings.お知らせ • Oct 04SRAX, Inc. Announces the Arcimoto SweepstakesSRAX, Inc. announced the launch of the SRAX Arcimoto Sweepstakes. The sweepstakes, open to the investor community, is live and will run until October 30. The grand prize of an Arcimoto FUV, a fully electric vehicle, will be awarded to the lucky winner during the first week of November. Arcimoto is on a mission to decrease emissions by transforming the way the company drive, while keeping it FUN. The FUV is the future of clean, affordable transportation, and both companies look forward to spreading Arcimoto’s mission in a unique way.お知らせ • Aug 23+ 1 more updateSRAX Announces Receipt of Anticipated Nasdaq Notice of Additional DelinquencySRAX, Inc. (“Company”) announced, as expected, that on August 17, 2022, the Company received an additional delinquency notification letter from the Listing Qualifications Staff (the Staff) of The Nasdaq Stock Market LLC due to the Company's continued non-compliance with Nasdaq Listing Rule 5250(c)(1), (the Rule) as a result of the Company's failure to timely file its Quarterly Report on Form 10-Q for the quarter ended March 31, 2022, and June 30, 2022, as well as the Annual Report ended December 31, 2022. As previously disclosed, the Company earlier received notice from the Staff regarding its non-compliance with the Rule following the Company's delay in the filing of its Annual Report on Form 10-K for the fiscal year ended December 31, 2021 and its Quarterly Report on Form 10-Q for the quarter ended March 31, 2022. On June 20 and 30 of 2022, the Company submitted a plan to regain compliance with Listing Rule 5250(c)(1) by becoming current in its obligations to file periodic financial reports (“Submission”). On July 1, 2022, the Company received notice from Nasdaq that based on the Submission, the Company was granted the extension until October 12, 2022 to regain compliance with Nasdaq’s continued listing rule as it relates to the untimely filings. As a result of this additional delinquency, the Company must submit an update to its original Submission by September 8, 2022, which indicates the Company’s plan to remedy all delinquent filings and indicate the progress the Company has made towards implementing the plan contained in its Submission. If the Company does not regain compliance by October 12, 2022, the Company may appeal the relevant delisting determination to a hearings panel pursuant to the procedures set in the applicable Nasdaq Listing Rules.Seeking Alpha • Aug 23Srax receives Nasdaq notice of additional delinquencySRAX (NASDAQ:SRAX) disclosed that it received an additional delinquency notice from the Nasdaq Stock Market on Aug.17. The exchange notified the company that it is not in compliance with Nasdaq Listing Rule 5250c on the timely of quarterly reports on Form 10-Q for the quarter ended March 31, 2022, and June 30, 2022, as well as the Annual Report ended December 31, 2022. As a result of this additional delinquency, the company will submit an update to its original submission by Sep.08, which indicates the company’s plan to remedy all delinquent filings and indicate the progress the company has made towards implementing the plan contained in its submission. In the event, if the company does not regain compliance by Oct.12, the company may appeal the relevant delisting determination to a hearings panel pursuant to the procedures set forth in the applicable Nasdaq Listing Rules.分析記事 • Aug 18Is There An Opportunity With SRAX, Inc.'s (NASDAQ:SRAX) 50% Undervaluation?Today we will run through one way of estimating the intrinsic value of SRAX, Inc. ( NASDAQ:SRAX ) by taking the...Price Target Changed • Aug 17Price target increased to US$10.50Up from US$9.75, the current price target is an average from 2 analysts. New target price is 305% above last closing price of US$2.59. Stock is down 37% over the past year. The company is forecast to post earnings per share of US$4.71 next year compared to a net loss per share of US$1.00 last year.Seeking Alpha • Aug 15SRAX announces $9.5M revolving credit facilitySRAX (NASDAQ:SRAX) on Monday announced a revolving credit facility, which allows the firm to draw up to $9.5M over the next 2 years. Repayment of the facility is based on a percentage of sales of SRAX's marketable securities from customers of its SaaS platform Sequire. The amount of the facility outstanding is convertible into shares at $15/share. The facility requires SRAX to repurchase a minimum of $1M shares under $5/share. "We are working diligently with auditors to get our 10K filled. As of this date, there are no significant deviations (+/- 3%) on the income statement that we presented in our annual update. Our auditors believe we will be able to file in the next few weeks," said SRAX CEO Christopher Miglino. SRAX also launched a website for investors to track the current value of its marketable securities portfolio.お知らせ • Jun 07SRAX, Inc. Provides Earnings Guidance for the First Quarter and Full Year 2022SRAX, Inc. provided earnings guidance for the first quarter and full year 2022. For the quarter, the company expected to be in the range of $11.5 million representing an increase of 20% over the fourth quarter and 250% over the previous year.For the year, the company expected to be in the range of $47 million to $50 million, representing an increase in the range of 65% to 75% versus 2021 revenue of $28.5 million.お知らせ • May 18SRAX, Inc. announced delayed 10-Q filingOn 05/17/2022, SRAX, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Apr 28SRAX, Inc. Receives Non-Compliance Notice from NasdaqOn April 19, 2022, SRAX, Inc. received a notice from the Listing Qualifications Department of the Nasdaq Stock Market LLC (Nasdaq") stating that the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) because it has not yet filed its Annual Report on Form 10-K for the year ended December 31, 2021 (the 2021 Form 10-K") with the Securities and Exchange Commission (the SEC"). Nasdaq Listing Rule 5250(c)(1) requires listed companies to timely file all required periodic financial reports with the SEC. Under Nasdaq rules, the Company has 60 calendar days from the date of the Nasdaq notification letter, or until June 20, 2022, to file the 2021 Form 10-K with the SEC to regain compliance. If the Company is unable to file the 2021 Form 10-K with the SEC by June 20, 2022, then the Company is permitted to submit a plan to regain compliance with the Nasdaq Listing Rules on or prior to that date. If Nasdaq accepts the Company's plan, then Nasdaq may grant an exception of up to 180 calendar days from the due date of the 2021 Form 10-K, or until October 12, 2022, to regain compliance. However, there can be no assurance that Nasdaq will accept the Company's plan to regain compliance or that the Company will be able to regain compliance within any extension period granted by Nasdaq. If the Company fails to timely regain compliance with Nasdaq's listing rules, the Class A Common Stock (Common Stock") of the Company will be subject to delisting on the Nasdaq Global Market. The Nasdaq notice has no immediate impact on the listing or trading of the Company's Common Stock on the Nasdaq Global Market. The Company is continuing to work diligently to finalize and file the 2021 Form 10-K as soon as possible within the timeline prescribed by Nasdaq.お知らせ • Apr 01SRAX, Inc. announced delayed annual 10-K filingOn 03/31/2022, SRAX, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.お知らせ • Jan 12SRAX, Inc. Provides Revenue Guidance for the First Quarter and Full Year of 2022SRAX, Inc. provided revenue guidance for the first quarter and full year of 2022. For the first quarter of 2022, the company expects revenue of $11.5 million, a 111% increase over the first quarter of 2021 revenue.Full-year 2022 guidance of $46 million - $48 million, an increase of 46% - 52% over 2021 unaudited revenue of approximately $31.5 million.分析記事 • Dec 06Is SRAX (NASDAQ:SRAX) A Risky Investment?Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Seeking Alpha • Nov 29SRAX Offers Value HereSRAX is growing substantially and produces operational profits. While it is paid partially in securities adding risk, especially in a down market, the company has plenty of sources of liquidity, should there be a need. We see growth to continue and the financial results improving further, although it's worth while to keep an eye on renewal rates, especially this quarter.Reported Earnings • Nov 20Third quarter 2021 earnings released: US$0.15 loss per share (vs US$0.45 loss in 3Q 2020)The company reported a solid third quarter result with reduced losses, improved revenues and improved control over expenses. Third quarter 2021 results: Revenue: US$8.31m (up 219% from 3Q 2020). Net loss: US$3.83m (loss narrowed 42% from 3Q 2020). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 87 percentage points per year, which is a significant difference in performance.Reported Earnings • Aug 21Second quarter 2021 earnings released: US$0.24 loss per share (vs US$0.38 loss in 2Q 2020)The company reported a solid second quarter result with improved revenues and control over costs, although losses increased. Second quarter 2021 results: Revenue: US$7.68m (up US$6.51m from 2Q 2020). Net loss: US$5.74m (loss widened 7.9% from 2Q 2020). Over the last 3 years on average, earnings per share has fallen by 51% per year but the company’s share price has remained flat, which means it is well ahead of earnings.分析記事 • Aug 20Does SRAX (NASDAQ:SRAX) Have A Healthy Balance Sheet?David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Seeking Alpha • Aug 19SRAX Is Booming, Except The Share PriceThe company's Sequire platform is booming and operationally profitable already. Their majority stake in BIGtoken will likely get under 50% so they don't have to consolidate results and their figures will improve whilst boosting their balance sheet. The company is launching a $10M buyback and $6.5M special dividend, whilst their stake in BIGtoken is worth hundreds of millions at least on paper, what's not to like? There are risks, dilution has been steep and their participations, while rising rapidly has considerable valuation risk.Major Estimate Revision • Aug 18Consensus forecasts updatedThe consensus outlook for 2021 has been updated. 2021 revenue forecast increased from US$27.5m to US$31.8m. EPS estimate fell from -US$0.41 to -US$0.69 per share. Software industry in the US expected to see average net income growth of 4.5% next year. Consensus price target of US$9.75 unchanged from last update. Share price rose 4.5% to US$4.14 over the past week.お知らせ • Aug 18SRAX, Inc. (NasdaqCM:SRAX) announces an Equity Buyback for $10 million worth of its shares.SRAX, Inc. (NasdaqCM:SRAX) announces a share repurchase program. Under the program, the company will repurchase up to $10 million worth of its shares.Price Target Changed • Aug 18Price target increased to US$9.75Up from US$8.58, the current price target is an average from 2 analysts. New target price is 130% above last closing price of US$4.23. Stock is up 57% over the past year.お知らせ • Jun 15SRAX Releases the 1x1 Meeting Feature on the Sequire Virtual Events PlatformSRAX, Inc. announced the release of its 1x1 Meeting Feature in the Sequire Virtual Events Platform. This new addition will allow companies to connect with existing and potential shareholders on an individual basis during an event. The new 1x1 feature is an addition to Sequire Audience, a tool that allows companies to launch their earnings calls, shareholder meetings and other customizable events. The 1x1 meeting feature is used during virtual conferences, and in the Sequire Audience product. With this addition, company representatives presenting at a Sequire hosted conference are able to: Create 1x1 meetings and make them visible to attendees. Announce their meetings to a broad or custom audience. Approve the attendee requests in advance and reschedule if necessary. Join the meeting (both video and audio available). Add meetings to their email calendars and download their schedule.お知らせ • May 19SRAX, Inc. announced delayed 10-Q filingOn 05/18/2021, SRAX, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • May 18+ 1 more updateSRAX, Inc. Provides Revenue Guidance for the Second Quarter of Fiscal 2021SRAX, Inc. provided revenue guidance for the second quarter of fiscal 2021. Second quarter revenue guidance reiterated at $7 million.Reported Earnings • Apr 03Full year 2020 earnings released: US$0.92 loss per share (vs US$1.36 loss in FY 2019)The company reported a solid full year result with reduced losses, improved revenues and improved control over expenses. Full year 2020 results: Revenue: US$8.65m (up 141% from FY 2019). Net loss: US$14.7m (loss narrowed 13% from FY 2019). Over the last 3 years on average, earnings per share has fallen by 15% per year but the company’s share price has increased by 2% per year, which means it is well ahead of earnings.お知らせ • Mar 31+ 1 more updateSRAX, Inc. Provides Revenue Guidance for the Second Quarter Of Fiscal Year 2021SRAX, Inc. provided revenue guidance for the second quarter Of fiscal year 2021. For the quarter, the company expects revenue of $7 million.お知らせ • Mar 16SRAX, Inc. Releases the Shelf Registration Feature on the Sequire PlatformSRAX, Inc. announced the release of its Shelf Registration Feature. This new Sequire addition combines data and technology to provide actionable insights to public companies in regards to their shelf availability. The new shelf registration feature joins many other unique and robust Sequire features such as warrant management, situation room, and shareholder surveys. The shelf feature enables shelf eligible users to review and keep track of their shelf registration and current shelf availability. Included with this is the Shelf Prediction Tool: a real-time application to explore potential market windows, showing the impact of market volatility and thus improving funding plans. Shelf Registration Feature benefits: Know what is available on your shelf at any time; Continuous importing of all data in real time; Seamless data additions for non-public share increases via the full-feature data editor; and Efficient, one-click predictions to explore the impact of market volatility. This feature brings additional value to the Sequire platform and is just the beginning of a series of features to be released in 2021.お知らせ • Mar 12Brock Pierce Joins SRAX Board of DirectorsSRAX, Inc. announced that Brock Pierce has joined the SRAX board of directors. Pierce has co-founded, advised, and funded over 100 companies to support the creation of new jobs and marketplaces through technological innovation including many blockchain technologies that have paved the way for cryptocurrency innovations. He continues to give back through his philanthropic efforts. He has been quoted on many occasions saying “a billionaire is a person who has a positive impact on a billion people.” In his continued efforts to give back, he ran as a candidate for President of the United States in the 2020 election. Brock was responsible for the formation of Five Delta, a company that SRAX Purchased in 2014. Five Delta had a number of patents around social media ad targeting. The team and technology went on to form SRAX MD, which SRAX then sold in 2018 to a private equity firm for close to $50M.Is New 90 Day High Low • Feb 02New 90-day high: US$3.95The company is up 51% from its price of US$2.62 on 03 November 2020. The American market is up 16% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Media industry, which is up 19% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is US$0.19 per share.分析記事 • Feb 01Does SRAX (NASDAQ:SRAX) Have A Healthy Balance Sheet?Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Is New 90 Day High Low • Dec 29New 90-day high: US$3.12The company is up 11% from its price of US$2.82 on 29 September 2020. The American market is up 14% over the last 90 days, indicating the company underperformed over that time. However, its price trend is similar to the Media industry, which is also up 11% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is US$1.26 per share.Major Estimate Revision • Nov 24Analysts update estimatesThe 2020 consensus revenue estimate increased from US$6.03m to US$8.19m. Earning per share (EPS) estimate was further reduced from -US$1.21 to -US$1.31 for the same period. The Media industry in the US is expected to see an average net income growth of 16% next year. The consensus price target of US$5.00 was unchanged from the last update. Share price stayed mostly flat at US$2.94 over the past week.お知らせ • Nov 21SRAX, Inc., Annual General Meeting, Dec 31, 2020SRAX, Inc., Annual General Meeting, Dec 31, 2020, at 11:00 Pacific Standard Time. Agenda: To consider election of directors; to consider ratification of the appointment of RBSM LLP as independent registered public accounting firm for 2020; to approve an advisory vote to approve executive compensation (non-binding); to approve an advisory vote to approve the frequency of holding future advisory votes on executive compensation every 1, 2, or 3 years (non-binding); and to transact such other business as may properly come before the annual meeting and any postponement thereof.Reported Earnings • Nov 18Third quarter 2020 earnings released: US$0.45 loss per shareThe company reported a decent third quarter result with improved revenues, although earnings and control over expenses were weaker. Third quarter 2020 results: Revenue: US$2.61m (up 161% from 3Q 2019). Net loss: US$6.57m (down US$7.98m from profit in 3Q 2019). Over the last 3 years on average, earnings per share has fallen by 9% per year but the company’s share price has fallen by 20% per year, which means it is performing significantly worse than earnings.お知らせ • Oct 31An undisclosed buyer acquired the remaining stake in the MD Asset of SRAX, Inc. (NasdaqCM:SRAX) for $8 million.An undisclosed buyer acquired the remaining stake in the MD Asset of SRAX, Inc. (NasdaqCM:SRAX) for $8 million on October 30, 2020. An undisclosed buyer completed the acquisition of the remaining stake in the the MD Asset of SRAX, Inc. (NasdaqCM:SRAX) on October 30, 2020.Is New 90 Day High Low • Oct 15New 90-day low: US$2.34The company is down 4.0% from its price of US$2.45 on 17 July 2020. The American market is up 11% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Media industry, which is up 8.0% over the same period.お知らせ • Oct 14SRAX, Inc. Announces Resignation of Kristoffer Nelson as Chief Operating Officer and as a Member of the Board, Effective October 16, 2020On October 8, 2020, Kristoffer Nelson informed the board of directors of SRAX, Inc. that he is resigning, effective October 16, 2020, as the Company’s chief operating officer and as a member of the Board. Mr. Nelson is resigning in order to pursue other business activities and not because of any disputes or disagreements with the Company, the Board, management, or the Company’s auditors on any matters relating to the Company’s operations, policies, procedures or practices.お知らせ • Sep 24+ 1 more updateSRAX, Inc. announced that it has received $14 million in funding from Serra Ventures, LLCSocial Reality, Inc. announced that it has entered into a financing agreement for a private placement of notes for gross proceeds of $20,000,000 on October 30, 2014. The notes issued will mature on October 30, 2017. The company also issued a five year warrant to purchase 2,900,000 shares of its common stock at an exercise price of $1 per share. The transaction included participation from SBIC Fund, a fund managed by Serra Ventures, LLC. The notes bear interest at the rate of 10% per annum payable in cash and 4% per annum payable in kind. The securities were issued pursuant to exemption under Regulation D. T.R. Winston & Company, LLC acted as agent in the transaction. T.R. Winston & Company, LLC received fees of $580,000 in the transaction. Victory Park Management, LLC acted as the administration and collateral agent to investors. On the same date, the company received $9,000,000 in its first tranche. On July 8, 2015, the company announced that it has received an additional $1,500,000 in the transaction. On October 26, 2015, the company announced that it has received an additional $1,400,000 in the tranche. On January 26, 2016, the company announced that it has received an additional $1,600,000 in the transaction. On February 16, 2016, Social Reality, Inc. (NasdaqCM:SRAX) closed the transaction. The company announced that it has received an additional $500,000 in the transaction. The company raised gross proceeds of $14,000,000 in the transaction.お知らせ • Sep 17+ 1 more updateSRAX, Inc. (NasdaqCM:SRAX) completed the acquisition of LD Micro, Inc.SRAX, Inc. (NasdaqCM:SRAX) entered into an agreement to acquire LD Micro, Inc. for $4 million on September 04, 2020. Cash Payment of $4 million in cash payable to acquire LD Micro, Inc as follows: $1 million at closing, $1 million on January 1, 2021, $1 million on April 1, 2021, and ($1 million on July 1, 2021, and subject to adjustment or off-set as provided for in this Agreement. As part of the transaction, Chris Lahiji Chief Executive Officer of LD Micro, Inc. will join SRAX’s board of directors. The transaction is expected to close next week. Mitchell Silberberg & Knupp LLP served as legal advisor to LD Micro. Law Offices of Raul Silvestre served as counsel for SRAX, Inc. SRAX, Inc. (NasdaqCM:SRAX) completed the acquisition of LD Micro, Inc. on September 16, 2020. LD Micro will be a wholly-owned subsidiary of SRAX. LD Micro will continue to employ Christopher Lahiji, its founder, as President.お知らせ • Jul 17SRAX, Inc. announced that it has received $13 million in fundingOn June 30, 2020, SRAX, Inc. (NasdaqCM:SRAX) closed the transaction. The company received $1,932,123.92 in funding pursuant to exemption provided under the Regulation D from 12 investors.お知らせ • Jul 05SRAX, Inc.(NasdaqCM:SRAX) dropped from Russell Microcap Growth IndexSRAX, Inc.(NasdaqCM:SRAX) dropped from Russell Microcap Growth Indexお知らせ • Jun 29SRAX, Inc. announced that it has received $11.8 million in fundingSRAX, Inc. (NasdaqCM:SRAX) announced that it has entered into securities purchase agreements led by existing institutional investors for private placement of senior secured convertible debentures and common stock purchase warrants for gross proceeds of $11,800,000 on June 25, 2020. The company has issued $14,772,727 principal amount original issue discount secured convertible debentures. The common stock purchase warrants are convertible into up to 6,295,435 shares of class A common stock at a conversion price of $2.50 per share. The debentures are convertible into common shares at a conversion price of $2.69 per share. The debentures are secured by a first priority security interest in substantially all of the company’s assets. The company has paid placement agent fees, legal fees, and other estimated offering expenses in connection with the transaction. The debentures bear an interest rate of 12% per year, payable quarterly. The debentures will mature on December 29, 2021, subject to 3 consecutive six-month extensions at the holder’s sole discretion, unless earlier redeemed or converted.株主還元SRAXUS SoftwareUS 市場7D20.0%-10.7%-3.3%1Y100.0%-12.6%22.3%株主還元を見る業界別リターン: SRAX過去 1 年間で-12.6 % の収益を上げたUS Software業界を上回りました。リターン対市場: SRAX過去 1 年間で22.3 % の収益を上げたUS市場を上回りました。価格変動Is SRAX's price volatile compared to industry and market?SRAX volatilitySRAX Average Weekly Movement2,005.8%Software Industry Average Movement9.9%Market Average Movement7.2%10% most volatile stocks in US Market16.6%10% least volatile stocks in US Market3.1%安定した株価: SRAXの株価は、 US市場と比較して過去 3 か月間で変動しています。時間の経過による変動: 過去 1 年間のSRAXのボラティリティの変化を判断するには データが不十分です。会社概要設立従業員CEO（最高経営責任者ウェブサイト2009n/aChris Miglinowww.srax.comSRAX, Inc.は、米国、カナダ、および国際的な上場企業と株主・投資家とのコミュニケーション強化に注力している。同社は、SaaSプラットフォーム「Sequire」を提供し、発行体が株主の行動や動向を追跡し、データに基づく洞察を活用してマーケティング・チャネル全体で株主とエンゲージすることを可能にしている。また、小規模・小型株市場における投資家向けカンファレンスの企画・開催も行っている。同社は、社内の営業・マーケティングチームを通じて、サービスのマーケティングと販売を行っている。同社は以前Social Reality, Inc.として知られていたが、2019年8月にSRAX, Inc.に社名を変更した。SRAX, Inc.は2009年に設立され、カリフォルニア州ウェストレイクビレッジに本社を置いている。もっと見るSRAX, Inc. 基礎のまとめSRAX の収益と売上を時価総額と比較するとどうか。SRAX 基礎統計学時価総額US$326.76k収益（TTM）-US$15.73m売上高(TTM)US$18.56m0.0xP/Sレシオ0.0xPER（株価収益率SRAX は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計SRAX 損益計算書（TTM）収益US$18.56m売上原価US$1.37m売上総利益US$17.18mその他の費用US$32.91m収益-US$15.73m直近の収益報告Jun 30, 2023次回決算日該当なし一株当たり利益（EPS）0グロス・マージン0.00%純利益率0.00%有利子負債／自己資本比率0.0%SRAX の長期的なパフォーマンスは？過去の実績と比較を見るView Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/06/09 20:43終値2026/06/09 00:00収益2023/06/30年間収益2022/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋SRAX, Inc. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。6 アナリスト機関Michael RindosAegis Capital CorporationMichael CrawfordB. Riley Securities, Inc.James McIlreeChardan Capital Markets, LLC3 その他のアナリストを表示
お知らせ • May 09DNA Holdings LLC entered into a definitive merger agreement to acquire remaining 65% stake in SRAX, Inc. (OTCPK:SRAX).DNA Holdings LLC entered into a definitive merger agreement to acquire remaining 65% stake in SRAX, Inc. (OTCPK:SRAX) on May 8, 2024. DNA has been a long term investor in SRAX and currently owns approximately 35% of the company. Upon closing, the shareholders of DNA will become the majority owners of SRAX’s outstanding common stock. Upon the completion of the merger, the public company plans to change its name to DNA Holdings Venture Inc and to request to change its ticker symbol, creating a public company which will allow investors to gain exposure to the most cutting edge Web3 technology projects. Christopher Miglino will act as the CEO of the combined entity. The boards of directors of SRAX and DNA have unanimously approved the proposed Transaction. The Transaction is subject to, among other things, the approval of both SRAX and DNA stockholders and satisfaction or waiver of the conditions stated in the Agreement.
お知らせ • Apr 04SRAX, Inc. announced that it has received $0.075 million in fundingOn April 2, 2024, SRAX, Inc. closed the transaction.
お知らせ • Mar 07SRAX, Inc. announced that it has received $0.075 million in fundingSRAX, Inc. announced that it has entered into definitive securities purchase agreements with a certain accredited and institutional investor to issue an Original Issue Discount Convertible Debenture at a price of $75,000 in the principal amount of $90,000 for gross proceeds of $75,000 on March 5, 2024. The Debentures will mature on February 28, 2026 and bear no interest per annum. The Debentures are convertible at the option of the holder into shares of our Class A common stock at an initial conversion price of $0.25 per share, subject to adjustment. The debentures issued are exempt from registration under the Securities Act of 1933, as amended in reliance on the exemption provided by Rule 506(b) of Regulation D and Section 4(a)(2) of the Securities Act.
お知らせ • Jul 18SRAX, Inc. Announces Resignation of Board MembersOn July 11 and July 13th, SRAX, Inc. announced that Marc Savas, Robert Jordan, Colleen DiClaudio and Brock Pierce resigned from the board of directors and their respective committee roles of SRAX. There were no disagreements between Marc Savas, Robert Jordan, Colleen DiClaudio and Brock Pierce and the Company. Their departure is not related to the operations, policies or practices of the Company, or any issues regarding accounting policies or practices. Brock Pierce will transition to the Advisory Board. Christopher Miglino shall remain as the Chairman of the Board and shall assume the Governance, Compensation and Audit Committee chairman roles.
お知らせ • Jul 10Alan Urban Resigns as the Chief Financial Officer of SRAX, IncOn July 5, 2023 Alan Urban resigned as the Chief Financial Officer of SRAX and has transitioned from the Chief Financial Officer of the company to a consultant to help the company complete its SEC Filings. Mr. Urban is resigning to exclusively focus his efforts on the companies’ fillings, and there were no disagreements between Mr. Urban and the Company. His departure is not related to the operations, policies or practices of the Company, or any issues regarding accounting policies or practices.
New Risk • Jun 08New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: US$9.90m This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (48% average weekly change). Market cap is less than US$10m (US$9.90m market cap). Minor Risk Shareholders have been diluted in the past year (11% increase in shares outstanding).
お知らせ • May 09DNA Holdings LLC entered into a definitive merger agreement to acquire remaining 65% stake in SRAX, Inc. (OTCPK:SRAX).DNA Holdings LLC entered into a definitive merger agreement to acquire remaining 65% stake in SRAX, Inc. (OTCPK:SRAX) on May 8, 2024. DNA has been a long term investor in SRAX and currently owns approximately 35% of the company. Upon closing, the shareholders of DNA will become the majority owners of SRAX’s outstanding common stock. Upon the completion of the merger, the public company plans to change its name to DNA Holdings Venture Inc and to request to change its ticker symbol, creating a public company which will allow investors to gain exposure to the most cutting edge Web3 technology projects. Christopher Miglino will act as the CEO of the combined entity. The boards of directors of SRAX and DNA have unanimously approved the proposed Transaction. The Transaction is subject to, among other things, the approval of both SRAX and DNA stockholders and satisfaction or waiver of the conditions stated in the Agreement.
お知らせ • Apr 04SRAX, Inc. announced that it has received $0.075 million in fundingOn April 2, 2024, SRAX, Inc. closed the transaction.
お知らせ • Mar 07SRAX, Inc. announced that it has received $0.075 million in fundingSRAX, Inc. announced that it has entered into definitive securities purchase agreements with a certain accredited and institutional investor to issue an Original Issue Discount Convertible Debenture at a price of $75,000 in the principal amount of $90,000 for gross proceeds of $75,000 on March 5, 2024. The Debentures will mature on February 28, 2026 and bear no interest per annum. The Debentures are convertible at the option of the holder into shares of our Class A common stock at an initial conversion price of $0.25 per share, subject to adjustment. The debentures issued are exempt from registration under the Securities Act of 1933, as amended in reliance on the exemption provided by Rule 506(b) of Regulation D and Section 4(a)(2) of the Securities Act.
お知らせ • Jul 18SRAX, Inc. Announces Resignation of Board MembersOn July 11 and July 13th, SRAX, Inc. announced that Marc Savas, Robert Jordan, Colleen DiClaudio and Brock Pierce resigned from the board of directors and their respective committee roles of SRAX. There were no disagreements between Marc Savas, Robert Jordan, Colleen DiClaudio and Brock Pierce and the Company. Their departure is not related to the operations, policies or practices of the Company, or any issues regarding accounting policies or practices. Brock Pierce will transition to the Advisory Board. Christopher Miglino shall remain as the Chairman of the Board and shall assume the Governance, Compensation and Audit Committee chairman roles.
お知らせ • Jul 10Alan Urban Resigns as the Chief Financial Officer of SRAX, IncOn July 5, 2023 Alan Urban resigned as the Chief Financial Officer of SRAX and has transitioned from the Chief Financial Officer of the company to a consultant to help the company complete its SEC Filings. Mr. Urban is resigning to exclusively focus his efforts on the companies’ fillings, and there were no disagreements between Mr. Urban and the Company. His departure is not related to the operations, policies or practices of the Company, or any issues regarding accounting policies or practices.
New Risk • Jun 08New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: US$9.90m This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (48% average weekly change). Market cap is less than US$10m (US$9.90m market cap). Minor Risk Shareholders have been diluted in the past year (11% increase in shares outstanding).
Reported Earnings • Jan 03First quarter 2022 earnings released: EPS: US$0.14 (vs US$0.57 loss in 1Q 2021)First quarter 2022 results: EPS: US$0.14 (up from US$0.57 loss in 1Q 2021). Revenue: US$7.50m (up 38% from 1Q 2021). Net income: US$3.73m (up US$14.8m from 1Q 2021). Profit margin: 50% (up from net loss in 1Q 2021). Revenue is forecast to grow 33% p.a. on average during the next 2 years, compared to a 13% growth forecast for the Software industry in the US. Over the last 3 years on average, earnings per share has fallen by 3% per year but the company’s share price has fallen by 15% per year, which means it is performing significantly worse than earnings.
Breakeven Date Change • Dec 31Forecast breakeven date pushed back to 2023The analyst covering SRAX previously expected the company to break even in 2022. New forecast suggests the company will make a profit of US$12.3m in 2023. Average annual earnings growth of 117% is required to achieve expected profit on schedule.
お知らせ • Dec 02SRAX, Inc., Annual General Meeting, Dec 31, 2022SRAX, Inc., Annual General Meeting, Dec 31, 2022, at 11:00 Pacific Standard Time. Agenda: To consider and approve Election of six (6) members to the board of directors (“Board”) to serve for the following year or until their respective successors are appointed and qualified; Ratification of the appointment of Marcum LLP as independent registered public accounting firm for 2022; and to discuss other matters.
Price Target Changed • Nov 16Price target increased to US$10.50Up from US$9.75, the current price target is an average from 2 analysts. New target price is 518% above last closing price of US$1.70. Stock is down 67% over the past year. The company is forecast to post earnings per share of US$0.32 next year compared to a net loss per share of US$0.41 last year.
お知らせ • Oct 22SRAX, Inc. Launches the Sequire Investor Community PlatformSRAX, Inc. has launched its beta program for retail and institutional investors - Sequire Community. The Sequire Community is an ever-growing community of like-minded individuals, education, and resources. Complementing Sequire’s suite of products connecting public companies with their shareholders, this new platform gives investors and companies the ability to interact in a different way - through virtual Q&A events that can be held alone or in addition to earnings calls. Companies will have the ability to: Create a company profile showcasing their bio, ticker, and stock price; Launch Q&A events; Answer verified investor’s questions; See the amount of stock owned by investors asking questions; Hear what is important to shareholders. Investors will have the opportunity to: Connect their brokerage account to become verified; Engage with companies directly by asking questions; Upvote other investor’s questions on a company’s profile; Give companies feedback; Explore company profiles and other investment opportunities. In the final version of the platform, companies and investors will be able to start threads, link websites into questions and answers, as well as upload images or graphs.
お知らせ • Oct 21SRAX Announces Receipt of Nasdaq Listing DeterminationOn October 20, 2022, SRAX, Inc. announced that on October 14, 2022, the company received notice from the Nasdaq Listing Qualifications Staff (the ‘Staff’) indicating that the Staff had determined to delist the Company’s securities from Nasdaq unless the Company timely requests a hearing before the Nasdaq Hearings Panel (the ‘Panel’). The Staff’s determination was based upon the Company’s non-compliance with the filing requirement set forth in Nasdaq Listing Rule 5250(c)(1). On October 12, 2022, the Company filed its Annual Report on Form 10-K for the fiscal year ended December 31, 2021 with the Securities and Exchange Commission (the ‘SEC’); however, the Company has not yet filed the Quarterly Reports on Form 10-Q for the quarters ended March 31, 2022 and June 30, 2022 with the SEC. The Company plans to timely request a hearing before the Panel and, in accordance with Nasdaq Listing Rule 5815(a)(1)(B), a stay of any further suspension or delisting action by Nasdaq at least pending the issuance of a decision and the expiration of any extension that may be granted by the Panel following the hearing. At the hearing, the Company will present its plan to evidence compliance with the Filing Requirement and request an extension of time to do so. The Company is diligently working to file all necessary periodic reports with the SEC as soon as practicable; however, there can be no assurance that the Panel will determine to continue the company’s listing on Nasdaq or that the Company will be able to timely satisfy the terms of any extension that may be granted by the Panel as a result of the hearing.
Seeking Alpha • Oct 20SRAX gets Nasdaq delisting notice, plans to appeal decisionSRAX (NASDAQ:SRAX) said Thursday it received a Nasdaq notice indicating that its shares will be delisted unless the firm timely requests a hearing before the Nasdaq Hearings Panel. Nasdaq's decision is based on SRAX's (SRAX) non-compliance with the filing requirement for continued listing. The company filed its annual report for the fiscal year ended Dec. 31, 2021 with the SEC on Oct. 12. But it has not yet filed the quarterly reports for the quarters ended Mar. 31 and Jun. 30. SRAX (SRAX) plans to timely request a hearing before the panel and stay any further suspension or delisting action by the exchange.
Reported Earnings • Oct 13Full year 2021 earnings released: US$0.41 loss per share (vs US$0.69 loss in FY 2020)Full year 2021 results: US$0.41 loss per share (improved from US$0.69 loss in FY 2020). Revenue: US$26.7m (up 312% from FY 2020). Net loss: US$9.70m (loss narrowed 3.6% from FY 2020). Revenue is forecast to grow 36% p.a. on average during the next 2 years, compared to a 13% growth forecast for the Software industry in the US. Over the last 3 years on average, earnings per share has fallen by 39% per year but the company’s share price has only fallen by 6% per year, which means it has not declined as severely as earnings.
お知らせ • Oct 04SRAX, Inc. Announces the Arcimoto SweepstakesSRAX, Inc. announced the launch of the SRAX Arcimoto Sweepstakes. The sweepstakes, open to the investor community, is live and will run until October 30. The grand prize of an Arcimoto FUV, a fully electric vehicle, will be awarded to the lucky winner during the first week of November. Arcimoto is on a mission to decrease emissions by transforming the way the company drive, while keeping it FUN. The FUV is the future of clean, affordable transportation, and both companies look forward to spreading Arcimoto’s mission in a unique way.
お知らせ • Aug 23+ 1 more updateSRAX Announces Receipt of Anticipated Nasdaq Notice of Additional DelinquencySRAX, Inc. (“Company”) announced, as expected, that on August 17, 2022, the Company received an additional delinquency notification letter from the Listing Qualifications Staff (the Staff) of The Nasdaq Stock Market LLC due to the Company's continued non-compliance with Nasdaq Listing Rule 5250(c)(1), (the Rule) as a result of the Company's failure to timely file its Quarterly Report on Form 10-Q for the quarter ended March 31, 2022, and June 30, 2022, as well as the Annual Report ended December 31, 2022. As previously disclosed, the Company earlier received notice from the Staff regarding its non-compliance with the Rule following the Company's delay in the filing of its Annual Report on Form 10-K for the fiscal year ended December 31, 2021 and its Quarterly Report on Form 10-Q for the quarter ended March 31, 2022. On June 20 and 30 of 2022, the Company submitted a plan to regain compliance with Listing Rule 5250(c)(1) by becoming current in its obligations to file periodic financial reports (“Submission”). On July 1, 2022, the Company received notice from Nasdaq that based on the Submission, the Company was granted the extension until October 12, 2022 to regain compliance with Nasdaq’s continued listing rule as it relates to the untimely filings. As a result of this additional delinquency, the Company must submit an update to its original Submission by September 8, 2022, which indicates the Company’s plan to remedy all delinquent filings and indicate the progress the Company has made towards implementing the plan contained in its Submission. If the Company does not regain compliance by October 12, 2022, the Company may appeal the relevant delisting determination to a hearings panel pursuant to the procedures set in the applicable Nasdaq Listing Rules.
Seeking Alpha • Aug 23Srax receives Nasdaq notice of additional delinquencySRAX (NASDAQ:SRAX) disclosed that it received an additional delinquency notice from the Nasdaq Stock Market on Aug.17. The exchange notified the company that it is not in compliance with Nasdaq Listing Rule 5250c on the timely of quarterly reports on Form 10-Q for the quarter ended March 31, 2022, and June 30, 2022, as well as the Annual Report ended December 31, 2022. As a result of this additional delinquency, the company will submit an update to its original submission by Sep.08, which indicates the company’s plan to remedy all delinquent filings and indicate the progress the company has made towards implementing the plan contained in its submission. In the event, if the company does not regain compliance by Oct.12, the company may appeal the relevant delisting determination to a hearings panel pursuant to the procedures set forth in the applicable Nasdaq Listing Rules.
分析記事 • Aug 18Is There An Opportunity With SRAX, Inc.'s (NASDAQ:SRAX) 50% Undervaluation?Today we will run through one way of estimating the intrinsic value of SRAX, Inc. ( NASDAQ:SRAX ) by taking the...
Price Target Changed • Aug 17Price target increased to US$10.50Up from US$9.75, the current price target is an average from 2 analysts. New target price is 305% above last closing price of US$2.59. Stock is down 37% over the past year. The company is forecast to post earnings per share of US$4.71 next year compared to a net loss per share of US$1.00 last year.
Seeking Alpha • Aug 15SRAX announces $9.5M revolving credit facilitySRAX (NASDAQ:SRAX) on Monday announced a revolving credit facility, which allows the firm to draw up to $9.5M over the next 2 years. Repayment of the facility is based on a percentage of sales of SRAX's marketable securities from customers of its SaaS platform Sequire. The amount of the facility outstanding is convertible into shares at $15/share. The facility requires SRAX to repurchase a minimum of $1M shares under $5/share. "We are working diligently with auditors to get our 10K filled. As of this date, there are no significant deviations (+/- 3%) on the income statement that we presented in our annual update. Our auditors believe we will be able to file in the next few weeks," said SRAX CEO Christopher Miglino. SRAX also launched a website for investors to track the current value of its marketable securities portfolio.
お知らせ • Jun 07SRAX, Inc. Provides Earnings Guidance for the First Quarter and Full Year 2022SRAX, Inc. provided earnings guidance for the first quarter and full year 2022. For the quarter, the company expected to be in the range of $11.5 million representing an increase of 20% over the fourth quarter and 250% over the previous year.For the year, the company expected to be in the range of $47 million to $50 million, representing an increase in the range of 65% to 75% versus 2021 revenue of $28.5 million.
お知らせ • May 18SRAX, Inc. announced delayed 10-Q filingOn 05/17/2022, SRAX, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Apr 28SRAX, Inc. Receives Non-Compliance Notice from NasdaqOn April 19, 2022, SRAX, Inc. received a notice from the Listing Qualifications Department of the Nasdaq Stock Market LLC (Nasdaq") stating that the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) because it has not yet filed its Annual Report on Form 10-K for the year ended December 31, 2021 (the 2021 Form 10-K") with the Securities and Exchange Commission (the SEC"). Nasdaq Listing Rule 5250(c)(1) requires listed companies to timely file all required periodic financial reports with the SEC. Under Nasdaq rules, the Company has 60 calendar days from the date of the Nasdaq notification letter, or until June 20, 2022, to file the 2021 Form 10-K with the SEC to regain compliance. If the Company is unable to file the 2021 Form 10-K with the SEC by June 20, 2022, then the Company is permitted to submit a plan to regain compliance with the Nasdaq Listing Rules on or prior to that date. If Nasdaq accepts the Company's plan, then Nasdaq may grant an exception of up to 180 calendar days from the due date of the 2021 Form 10-K, or until October 12, 2022, to regain compliance. However, there can be no assurance that Nasdaq will accept the Company's plan to regain compliance or that the Company will be able to regain compliance within any extension period granted by Nasdaq. If the Company fails to timely regain compliance with Nasdaq's listing rules, the Class A Common Stock (Common Stock") of the Company will be subject to delisting on the Nasdaq Global Market. The Nasdaq notice has no immediate impact on the listing or trading of the Company's Common Stock on the Nasdaq Global Market. The Company is continuing to work diligently to finalize and file the 2021 Form 10-K as soon as possible within the timeline prescribed by Nasdaq.
お知らせ • Apr 01SRAX, Inc. announced delayed annual 10-K filingOn 03/31/2022, SRAX, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
お知らせ • Jan 12SRAX, Inc. Provides Revenue Guidance for the First Quarter and Full Year of 2022SRAX, Inc. provided revenue guidance for the first quarter and full year of 2022. For the first quarter of 2022, the company expects revenue of $11.5 million, a 111% increase over the first quarter of 2021 revenue.Full-year 2022 guidance of $46 million - $48 million, an increase of 46% - 52% over 2021 unaudited revenue of approximately $31.5 million.
分析記事 • Dec 06Is SRAX (NASDAQ:SRAX) A Risky Investment?Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Seeking Alpha • Nov 29SRAX Offers Value HereSRAX is growing substantially and produces operational profits. While it is paid partially in securities adding risk, especially in a down market, the company has plenty of sources of liquidity, should there be a need. We see growth to continue and the financial results improving further, although it's worth while to keep an eye on renewal rates, especially this quarter.
Reported Earnings • Nov 20Third quarter 2021 earnings released: US$0.15 loss per share (vs US$0.45 loss in 3Q 2020)The company reported a solid third quarter result with reduced losses, improved revenues and improved control over expenses. Third quarter 2021 results: Revenue: US$8.31m (up 219% from 3Q 2020). Net loss: US$3.83m (loss narrowed 42% from 3Q 2020). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 87 percentage points per year, which is a significant difference in performance.
Reported Earnings • Aug 21Second quarter 2021 earnings released: US$0.24 loss per share (vs US$0.38 loss in 2Q 2020)The company reported a solid second quarter result with improved revenues and control over costs, although losses increased. Second quarter 2021 results: Revenue: US$7.68m (up US$6.51m from 2Q 2020). Net loss: US$5.74m (loss widened 7.9% from 2Q 2020). Over the last 3 years on average, earnings per share has fallen by 51% per year but the company’s share price has remained flat, which means it is well ahead of earnings.
分析記事 • Aug 20Does SRAX (NASDAQ:SRAX) Have A Healthy Balance Sheet?David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Seeking Alpha • Aug 19SRAX Is Booming, Except The Share PriceThe company's Sequire platform is booming and operationally profitable already. Their majority stake in BIGtoken will likely get under 50% so they don't have to consolidate results and their figures will improve whilst boosting their balance sheet. The company is launching a $10M buyback and $6.5M special dividend, whilst their stake in BIGtoken is worth hundreds of millions at least on paper, what's not to like? There are risks, dilution has been steep and their participations, while rising rapidly has considerable valuation risk.
Major Estimate Revision • Aug 18Consensus forecasts updatedThe consensus outlook for 2021 has been updated. 2021 revenue forecast increased from US$27.5m to US$31.8m. EPS estimate fell from -US$0.41 to -US$0.69 per share. Software industry in the US expected to see average net income growth of 4.5% next year. Consensus price target of US$9.75 unchanged from last update. Share price rose 4.5% to US$4.14 over the past week.
お知らせ • Aug 18SRAX, Inc. (NasdaqCM:SRAX) announces an Equity Buyback for $10 million worth of its shares.SRAX, Inc. (NasdaqCM:SRAX) announces a share repurchase program. Under the program, the company will repurchase up to $10 million worth of its shares.
Price Target Changed • Aug 18Price target increased to US$9.75Up from US$8.58, the current price target is an average from 2 analysts. New target price is 130% above last closing price of US$4.23. Stock is up 57% over the past year.
お知らせ • Jun 15SRAX Releases the 1x1 Meeting Feature on the Sequire Virtual Events PlatformSRAX, Inc. announced the release of its 1x1 Meeting Feature in the Sequire Virtual Events Platform. This new addition will allow companies to connect with existing and potential shareholders on an individual basis during an event. The new 1x1 feature is an addition to Sequire Audience, a tool that allows companies to launch their earnings calls, shareholder meetings and other customizable events. The 1x1 meeting feature is used during virtual conferences, and in the Sequire Audience product. With this addition, company representatives presenting at a Sequire hosted conference are able to: Create 1x1 meetings and make them visible to attendees. Announce their meetings to a broad or custom audience. Approve the attendee requests in advance and reschedule if necessary. Join the meeting (both video and audio available). Add meetings to their email calendars and download their schedule.
お知らせ • May 19SRAX, Inc. announced delayed 10-Q filingOn 05/18/2021, SRAX, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • May 18+ 1 more updateSRAX, Inc. Provides Revenue Guidance for the Second Quarter of Fiscal 2021SRAX, Inc. provided revenue guidance for the second quarter of fiscal 2021. Second quarter revenue guidance reiterated at $7 million.
Reported Earnings • Apr 03Full year 2020 earnings released: US$0.92 loss per share (vs US$1.36 loss in FY 2019)The company reported a solid full year result with reduced losses, improved revenues and improved control over expenses. Full year 2020 results: Revenue: US$8.65m (up 141% from FY 2019). Net loss: US$14.7m (loss narrowed 13% from FY 2019). Over the last 3 years on average, earnings per share has fallen by 15% per year but the company’s share price has increased by 2% per year, which means it is well ahead of earnings.
お知らせ • Mar 31+ 1 more updateSRAX, Inc. Provides Revenue Guidance for the Second Quarter Of Fiscal Year 2021SRAX, Inc. provided revenue guidance for the second quarter Of fiscal year 2021. For the quarter, the company expects revenue of $7 million.
お知らせ • Mar 16SRAX, Inc. Releases the Shelf Registration Feature on the Sequire PlatformSRAX, Inc. announced the release of its Shelf Registration Feature. This new Sequire addition combines data and technology to provide actionable insights to public companies in regards to their shelf availability. The new shelf registration feature joins many other unique and robust Sequire features such as warrant management, situation room, and shareholder surveys. The shelf feature enables shelf eligible users to review and keep track of their shelf registration and current shelf availability. Included with this is the Shelf Prediction Tool: a real-time application to explore potential market windows, showing the impact of market volatility and thus improving funding plans. Shelf Registration Feature benefits: Know what is available on your shelf at any time; Continuous importing of all data in real time; Seamless data additions for non-public share increases via the full-feature data editor; and Efficient, one-click predictions to explore the impact of market volatility. This feature brings additional value to the Sequire platform and is just the beginning of a series of features to be released in 2021.
お知らせ • Mar 12Brock Pierce Joins SRAX Board of DirectorsSRAX, Inc. announced that Brock Pierce has joined the SRAX board of directors. Pierce has co-founded, advised, and funded over 100 companies to support the creation of new jobs and marketplaces through technological innovation including many blockchain technologies that have paved the way for cryptocurrency innovations. He continues to give back through his philanthropic efforts. He has been quoted on many occasions saying “a billionaire is a person who has a positive impact on a billion people.” In his continued efforts to give back, he ran as a candidate for President of the United States in the 2020 election. Brock was responsible for the formation of Five Delta, a company that SRAX Purchased in 2014. Five Delta had a number of patents around social media ad targeting. The team and technology went on to form SRAX MD, which SRAX then sold in 2018 to a private equity firm for close to $50M.
Is New 90 Day High Low • Feb 02New 90-day high: US$3.95The company is up 51% from its price of US$2.62 on 03 November 2020. The American market is up 16% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Media industry, which is up 19% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is US$0.19 per share.
分析記事 • Feb 01Does SRAX (NASDAQ:SRAX) Have A Healthy Balance Sheet?Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Is New 90 Day High Low • Dec 29New 90-day high: US$3.12The company is up 11% from its price of US$2.82 on 29 September 2020. The American market is up 14% over the last 90 days, indicating the company underperformed over that time. However, its price trend is similar to the Media industry, which is also up 11% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is US$1.26 per share.
Major Estimate Revision • Nov 24Analysts update estimatesThe 2020 consensus revenue estimate increased from US$6.03m to US$8.19m. Earning per share (EPS) estimate was further reduced from -US$1.21 to -US$1.31 for the same period. The Media industry in the US is expected to see an average net income growth of 16% next year. The consensus price target of US$5.00 was unchanged from the last update. Share price stayed mostly flat at US$2.94 over the past week.
お知らせ • Nov 21SRAX, Inc., Annual General Meeting, Dec 31, 2020SRAX, Inc., Annual General Meeting, Dec 31, 2020, at 11:00 Pacific Standard Time. Agenda: To consider election of directors; to consider ratification of the appointment of RBSM LLP as independent registered public accounting firm for 2020; to approve an advisory vote to approve executive compensation (non-binding); to approve an advisory vote to approve the frequency of holding future advisory votes on executive compensation every 1, 2, or 3 years (non-binding); and to transact such other business as may properly come before the annual meeting and any postponement thereof.
Reported Earnings • Nov 18Third quarter 2020 earnings released: US$0.45 loss per shareThe company reported a decent third quarter result with improved revenues, although earnings and control over expenses were weaker. Third quarter 2020 results: Revenue: US$2.61m (up 161% from 3Q 2019). Net loss: US$6.57m (down US$7.98m from profit in 3Q 2019). Over the last 3 years on average, earnings per share has fallen by 9% per year but the company’s share price has fallen by 20% per year, which means it is performing significantly worse than earnings.
お知らせ • Oct 31An undisclosed buyer acquired the remaining stake in the MD Asset of SRAX, Inc. (NasdaqCM:SRAX) for $8 million.An undisclosed buyer acquired the remaining stake in the MD Asset of SRAX, Inc. (NasdaqCM:SRAX) for $8 million on October 30, 2020. An undisclosed buyer completed the acquisition of the remaining stake in the the MD Asset of SRAX, Inc. (NasdaqCM:SRAX) on October 30, 2020.
Is New 90 Day High Low • Oct 15New 90-day low: US$2.34The company is down 4.0% from its price of US$2.45 on 17 July 2020. The American market is up 11% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Media industry, which is up 8.0% over the same period.
お知らせ • Oct 14SRAX, Inc. Announces Resignation of Kristoffer Nelson as Chief Operating Officer and as a Member of the Board, Effective October 16, 2020On October 8, 2020, Kristoffer Nelson informed the board of directors of SRAX, Inc. that he is resigning, effective October 16, 2020, as the Company’s chief operating officer and as a member of the Board. Mr. Nelson is resigning in order to pursue other business activities and not because of any disputes or disagreements with the Company, the Board, management, or the Company’s auditors on any matters relating to the Company’s operations, policies, procedures or practices.
お知らせ • Sep 24+ 1 more updateSRAX, Inc. announced that it has received $14 million in funding from Serra Ventures, LLCSocial Reality, Inc. announced that it has entered into a financing agreement for a private placement of notes for gross proceeds of $20,000,000 on October 30, 2014. The notes issued will mature on October 30, 2017. The company also issued a five year warrant to purchase 2,900,000 shares of its common stock at an exercise price of $1 per share. The transaction included participation from SBIC Fund, a fund managed by Serra Ventures, LLC. The notes bear interest at the rate of 10% per annum payable in cash and 4% per annum payable in kind. The securities were issued pursuant to exemption under Regulation D. T.R. Winston & Company, LLC acted as agent in the transaction. T.R. Winston & Company, LLC received fees of $580,000 in the transaction. Victory Park Management, LLC acted as the administration and collateral agent to investors. On the same date, the company received $9,000,000 in its first tranche. On July 8, 2015, the company announced that it has received an additional $1,500,000 in the transaction. On October 26, 2015, the company announced that it has received an additional $1,400,000 in the tranche. On January 26, 2016, the company announced that it has received an additional $1,600,000 in the transaction. On February 16, 2016, Social Reality, Inc. (NasdaqCM:SRAX) closed the transaction. The company announced that it has received an additional $500,000 in the transaction. The company raised gross proceeds of $14,000,000 in the transaction.
お知らせ • Sep 17+ 1 more updateSRAX, Inc. (NasdaqCM:SRAX) completed the acquisition of LD Micro, Inc.SRAX, Inc. (NasdaqCM:SRAX) entered into an agreement to acquire LD Micro, Inc. for $4 million on September 04, 2020. Cash Payment of $4 million in cash payable to acquire LD Micro, Inc as follows: $1 million at closing, $1 million on January 1, 2021, $1 million on April 1, 2021, and ($1 million on July 1, 2021, and subject to adjustment or off-set as provided for in this Agreement. As part of the transaction, Chris Lahiji Chief Executive Officer of LD Micro, Inc. will join SRAX’s board of directors. The transaction is expected to close next week. Mitchell Silberberg & Knupp LLP served as legal advisor to LD Micro. Law Offices of Raul Silvestre served as counsel for SRAX, Inc. SRAX, Inc. (NasdaqCM:SRAX) completed the acquisition of LD Micro, Inc. on September 16, 2020. LD Micro will be a wholly-owned subsidiary of SRAX. LD Micro will continue to employ Christopher Lahiji, its founder, as President.
お知らせ • Jul 17SRAX, Inc. announced that it has received $13 million in fundingOn June 30, 2020, SRAX, Inc. (NasdaqCM:SRAX) closed the transaction. The company received $1,932,123.92 in funding pursuant to exemption provided under the Regulation D from 12 investors.
お知らせ • Jul 05SRAX, Inc.(NasdaqCM:SRAX) dropped from Russell Microcap Growth IndexSRAX, Inc.(NasdaqCM:SRAX) dropped from Russell Microcap Growth Index
お知らせ • Jun 29SRAX, Inc. announced that it has received $11.8 million in fundingSRAX, Inc. (NasdaqCM:SRAX) announced that it has entered into securities purchase agreements led by existing institutional investors for private placement of senior secured convertible debentures and common stock purchase warrants for gross proceeds of $11,800,000 on June 25, 2020. The company has issued $14,772,727 principal amount original issue discount secured convertible debentures. The common stock purchase warrants are convertible into up to 6,295,435 shares of class A common stock at a conversion price of $2.50 per share. The debentures are convertible into common shares at a conversion price of $2.69 per share. The debentures are secured by a first priority security interest in substantially all of the company’s assets. The company has paid placement agent fees, legal fees, and other estimated offering expenses in connection with the transaction. The debentures bear an interest rate of 12% per year, payable quarterly. The debentures will mature on December 29, 2021, subject to 3 consecutive six-month extensions at the holder’s sole discretion, unless earlier redeemed or converted.
